Skip to main content

UBS Group AG

Position in XGN — Exagen Inc.

CIK 1610520 ZURICH, V8

Position in XGN

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$83,712
-$603,260 QoQ
Shares Held
27,904
-75.3% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

UBS Group AG holds $3,683,964,878 across 46 Diagnostics & Research names. XGN ranks #36 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $83,712 27,904
2025-12-31 $686,972 112,989
2025-09-30 $989,220 90,011
2025-06-30 $3,114,524 446,207
2025-03-31 $224,432 62,516
2024-12-31 $263,289 64,217
2024-09-30 $242,647 78,527
2024-06-30 $113,779 62,516
2024-03-31 $99,400 62,516
2023-12-31 $124,193 62,409
2023-09-30 $316,615 130,833
2023-06-30 $379,415 130,833
2023-03-31 $317,924 130,833
2022-12-31 $328,434 136,848
2022-09-30 $370,762 136,813
2022-06-30 $755,779 131,669
2022-03-31 $1,059,695 131,967
2021-12-31 $1,579,248 135,791
2021-09-30 $1,766,625 129,899
2021-06-30 $1,937,022 129,221
2021-03-31 $2,319,852 132,563
2020-12-31 $11,352 860
2020-09-30 $487 45
2020-06-30 $18,751 1,511
2020-03-31 $30,700 1,926